Edgar Engleman
Founder presso BOLT BIOTHERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Edgar Engleman, M.D.
is a founding member and Chief Scientific Advisor of Vivo Capital.
Dr. Engleman is a Professor of Pathology and Medicine at the Stanford University School of Medicine, where he established and oversees the Stanford Blood Center, directs his immunology research team, and co-directs the Tumor Immunology and Immunotherapy Research Programs at the Stanford Cancer Institute.
He is an inventor of multiple patented technologies, has authored more than 300 publications in medical and scientific journals, and trained more than 100 graduate and postgraduate students.
Dr. Engleman is the lead inventor of the technology underlying a cancer immunotherapy known as Provenge (Sipulucel-T), which was shown to extend the life of patients who suffer from metastatic prostate cancer.
Provenge is the first in the class of personalized immunotherapeutic agents to be FDA approved for the treatment of cancer.
He is also the lead inventor of the technology underlying the immunotherapies in development at Bolt Biotherapeutics.
Dr. Engleman is the founder or cofounder of a number of biotech companies including Cetus Immune (acquired by Novartis), Genelabs (acquired by GlaxoSmithKline), Dendreon (acquired by Sanpower), and Vivo portfolio companies Medeor, Bolt, and Tranquis.
He currently serves on the boards of Bolt (BOLT) and several private companies including Tranquis, Synapse and Ossium.
He previously served on the boards of REGENEXBIO (RGNX), Eiger (EIGR), Soleno (SLNO), Intermune (ITMN, acquired by Roche), Insmed (INSM), Prestwick (acquired by Biovail) and Semnur (acquired by Sorrento (SRNE).
He received his BA from Harvard College and earned his M.D.
from Columbia University School of Medicine.
In 2017, he received the CABS K Fong Prize in Life Sciences for his biomedical discoveries and contributions.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
12/06/2023 | 1 278 227 ( 3.35% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Edgar Engleman
Società | Posizione | Inizio |
---|---|---|
BOLT BIOTHERAPEUTICS, INC. | Founder | 22/01/2015 |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Founder | 01/01/1996 |
Ossium Health, Inc.
Ossium Health, Inc. Miscellaneous Commercial ServicesCommercial Services Ossium Health, Inc. provides biotechnology services. It offers bone marrow banking, cryopreservation, stem cell biology, therapy and cell transplant. The company was founded by Sebastian Eriksson Giwa, Kevin Caldwell and Erik Woods in 2016 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Vivo Co-Invest (S) LP | Director/Board Member | - |
Neurocea LLC
Neurocea LLC Pharmaceuticals: MajorHealth Technology Neurocea LLC operates as a biopharmaceutical company which develops innovative small molecule therapeutics for the treatment and prevention of falls and movement disorders. The company was founded by Arasteh Ari Azhir and Edgar G. Engleman and is headquartered in Los Altos, CA. | Founder | - |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Director/Board Member | - |
Stanford University School of Medicine | Corporate Officer/Principal | 01/01/1990 |
Precedenti posizioni note di Edgar Engleman
Società | Posizione | Fine |
---|---|---|
SOLENO THERAPEUTICS, INC. | Director/Board Member | 31/12/2017 |
EIGER BIOPHARMACEUTICALS, INC. | Director/Board Member | 18/09/2017 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Edgar Engleman
Harvard University | Undergraduate Degree |
Columbia University College of Physicians & Surgeons | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
INSMED INCORPORATED | Health Technology |
SOLENO THERAPEUTICS, INC. | Health Technology |
REGENXBIO INC. | Health Technology |
BOLT BIOTHERAPEUTICS, INC. | Health Technology |
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Aziende private | 21 |
---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Pepgen Corp.
Pepgen Corp. Pharmaceuticals: MajorHealth Technology Pepgen Corp. was a biopharmaceutical company. Its product was Tauferon. The company was founded by C. P. Liu in 1992 and was headquartered in Alameda, CA. | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
Nuveta, Inc.
Nuveta, Inc. Medical SpecialtiesHealth Technology Nuveta, Inc. focused on the development and commercialization of new applications that significantly improve IVF therapy. It explored key scientific questions of in vitro embryo growth and uses these findings to create new methods. The company was founded by George Tidmarsh in 2009 and was headquartered in Portola Valley, CA. | Health Technology |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
CellGate Technologies LLC
CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a private company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Electronic Technology |
Cellgate, Inc.
Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Health Technology |
Neuraltus Pharmaceuticals, Inc.
Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
Cetus Immune | |
Neurocea LLC
Neurocea LLC Pharmaceuticals: MajorHealth Technology Neurocea LLC operates as a biopharmaceutical company which develops innovative small molecule therapeutics for the treatment and prevention of falls and movement disorders. The company was founded by Arasteh Ari Azhir and Edgar G. Engleman and is headquartered in Los Altos, CA. | Health Technology |
Ossium Health, Inc.
Ossium Health, Inc. Miscellaneous Commercial ServicesCommercial Services Ossium Health, Inc. provides biotechnology services. It offers bone marrow banking, cryopreservation, stem cell biology, therapy and cell transplant. The company was founded by Sebastian Eriksson Giwa, Kevin Caldwell and Erik Woods in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
Dendreon Pharmaceuticals LLC
Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Health Technology |
Tranquis Therapeutics, Inc.
Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Health Technology |
Intermun, Inc.
Intermun, Inc. Pharmaceuticals: MajorHealth Technology Intermun, Inc. is a Canadian company that manufactures pharmaceuticals. | Health Technology |
Vivo Co-Invest (S) LP |
- Borsa valori
- Insiders
- Edgar Engleman